Cargando…
Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
Autores principales: | Ma, Yuxiang, Zhao, Xin, Chen, Xi, Huang, Xinxin, Lin, Qingguang, Lin, Yuehao, Salamone, Salvatore J, Zhou, Xinlan, Wang, Changzheng, Liang, Weiting, Zhao, Hongyun, Wu, Kui, Yang, Yunpeng, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021539/ https://www.ncbi.nlm.nih.gov/pubmed/33931979 http://dx.doi.org/10.1002/ctm2.354 |
Ejemplares similares
-
Clinical pharmacokinetics and drug exposure-toxicity correlation study of docetaxel based chemotherapy in Chinese head and neck cancer patients
por: Ma, Yuxiang, et al.
Publicado: (2020) -
Population Pharmacokinetic Analysis of Pazopanib in Patients and Determination of Target AUC
por: Ozbey, Agustos Cetin, et al.
Publicado: (2021) -
Direct AUC optimization of regulatory motifs
por: Zhu, Lin, et al.
Publicado: (2017) -
The Open AUC Project
por: Cölfen, Helmut, et al.
Publicado: (2009) -
Pharmacokinetic evaluation of MFF in combinations with tacrolimus and cyclosporine. Findings of C(0) and AUC
por: Radzevičienė, Aurelija, et al.
Publicado: (2020)